Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Byoung Deok Kim"'
Autor:
Chang Hyun Kim, Byoung Deok Kim, Tae Hwa Lee, Hyeon Kyun Kim, Min Jeong Lyu, Young In Yoon, Yoon Tae Goo, Myung Joo Kang, Sangkil Lee, Young Wook Choi
Publikováno v:
Cancer Nanotechnology, Vol 13, Iss 1, Pp 1-26 (2022)
Abstract Background A targeted co-administration system of docetaxel (DTX) and curcumin (CUR) using a PEG-modified RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated nanostructured lipid carrier (P/R-NLC) was constructed to exert synergistic anticancer effec
Externí odkaz:
https://doaj.org/article/2ba3dd2ef6c54b7294f1a3e91c80441e
Autor:
Chang Hyun Kim, Tae Hwa Lee, Byoung Deok Kim, Hyeon Kyun Kim, Min Jeong Lyu, Hyun Min Jung, Yoon Tae Goo, Myung Joo Kang, Sangkil Lee, Young Wook Choi
Publikováno v:
Journal of Drug Delivery Science and Technology. 71:103323
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc8d28122e518be882b381cc52b956f4
https://doi.org/10.1016/j.jddst.2022.103323
https://doi.org/10.1016/j.jddst.2022.103323
Autor:
Yong Seok Choi, Yoon Tae Goo, Chang Hyun Kim, Myung Joo Kang, Young Wook Choi, Tae Hoon Kang, Ho Yub Yoon, Byoung Deok Kim, Tae Hwa Lee
Publikováno v:
International journal of pharmaceutics. 583
Docetaxel (DTX) has poor solubility, low specificity, and severe side effects. For efficient targeting of DTX to hepsin-overexpressing SKOV3 ovarian cancer cells, PEGylated and RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated nanostructured lipid carriers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40e80126e91cf20347b5932de1d000aa
https://pubmed.ncbi.nlm.nih.gov/32376445
https://pubmed.ncbi.nlm.nih.gov/32376445